INTRODUCTION
============

Apoptosis is an intrinsic cell death process that plays critical roles in the normal development and health of multicellular organisms. However, in the last years, growing evidence suggests that apoptosis-like cell death also occurs in a number of unicellular organisms, including yeast ([@B87], [@B89]; [@B164]; [@B122]; [@B18]; [@B148]). Some features of apoptotic-like cell death can be induced in yeast following stress conditions, such as acetic acid ([@B86], [@B85]), membrane-permeable C2-ceramide ([@B19]), hydrogen peroxide (H~2~O~2~; [@B88]; [@B132]), hyperosmotic ([@B142]; [@B132]), and NaCl ([@B64]; [@B161]) stress.

Cell membranes are structurally heterogeneous, composed of discrete domains with unique physical and biological properties. The concept of the organization of membrane lipid components into domains ([@B67]), and the subsequent demonstration of the existence in the plasma membrane of a particular type of microdomain enriched in sterols and sphingolipids, named as lipid rafts ([@B144]; [@B15]; [@B145]; [@B65]; [@B99]), have profoundly changed our view of membrane organization and membrane-regulated processes. Membrane domains can form through a number of mechanisms involving lipid--lipid and protein--lipid interactions.

Despite lipid rafts have different sizes depending on the membrane composition, a consensus definition of a lipid raft developed at the 2006 Keystone Symposium of Lipid Rafts and Cell Function, held in Steamboat Springs (CO, USA), concluded that "membrane rafts are small (10--200 nm), heterogenous, highly dynamic, sterol- and sphingolipid-enriched domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein--protein and protein--lipid interactions" ([@B125]). In resting cells, rafts appear small and unstable, and the current consensus is that their sizes are smaller than the optical diffraction limit (250 nm). Following stimulation, raft-preferring proteins are clustered, inducing larger and stabilized rafts, likely through lipid lateral diffusion and coalescence of small raft units.

A critical issue in the studies of raft biology lies in the difficulty to visualize rafts in living cells, unless they coalesce in large raft platforms. Thus, most of the evidence for their identification relies on indirect methods, such as the use of non-ionic detergent extraction. On these grounds, rafts are usually defined as the insoluble fraction or detergent-resistant membrane (a.k.a., DRM) after non-ionic detergent solubilization at 4^°^C, which can be isolated by flotation in density gradients. The association of a protein with cholesterol-rich rafts is strengthened when it becomes detergent-soluble after depletion of cholesterol from the membrane by the use of methyl-β-cyclodextrin or other agents. Nevertheless, the physiological existence of rafts has been challenged by a number of criticisms ([@B114]; [@B81]; [@B82]; [@B143]), in particular regarding the use of detergents that could lead to artifacts and misinterpretations since, for instance, Triton has been shown to promote the formation of ordered domains in model bilayers ([@B61]). Also, a main concern has been raised on the diverse effects that might be expected by depleting cholesterol from the membrane because cholesterol has important functions in the whole plasma membrane, apart from forming lipid rafts. On these grounds, the functional involvement of rafts as well as the raft localization of proteins based only on the use of detergents and cholesterol depletion has been challenged, and therefore caution should be taken before assigning a role of rafts in different biological processes. In addition, the evidence for the presence of rafts in the plasma membrane of living cells has, until recently, not been compelling, thus raising some doubts about the physiological existence of rafts. However, the advent of new microscopy techniques has finally demonstrated the existence of rafts in the cell. The use of stimulated emission depletion (STED) microscopy has proved that sphingolipids and glycosylphosphatidylinositol (GPI)-anchored proteins are transiently trapped in cholesterol-dependent molecular complexes in live cells ([@B35]). In this regard, the application of novel technologies, such as fluorescence resonance energy transfer (FRET), fluorescence polarization anisotropy (FPA), total internal reflection fluorescence (TIRF) microscopy, single quantum dot tracking, single particle tracking (SPT), and fluorescence correlation spectroscopy (FCS), have provided evidence for the localization of GPI-anchored proteins and other lipid-modified proteins in cholesterol-dependent clusters ([@B73]; [@B139]; [@B79]; [@B96]; [@B158]; [@B126]). In addition, near-field scanning optical microscopy (NSOM) in combination with quantum dots showed that T cell stimulation triggers the organization of T cell receptors in nanodomains in live cells ([@B173]; [@B157]). The development of the above high temporal and spatial resolution techniques has allowed to locate different molecular constituents in membrane domains with reduced mobility. The combined use of different biophysical, biochemical, and genetic technologies are now providing evidence demonstrating the existence of sterol-dependent membrane raft domains as well as their role in critical physiological functions. Despite some technical and conceptual limitations, as stated above, resistance to non-ionic detergent solubilization, together with flotation in gradient density centrifugation and manipulation of sterol, remain as the most widely used techniques for studying lipid rafts.

There are a wide number of reports showing that rafts in mammalian cells house proteins involved in cell survival and growth, as well as in the proper functioning of immune system receptors ([@B145]; [@B150]). In this regard, cancer cells, usually showing an increased ability to proliferate and survive, have been found to have higher levels of cholesterol ([@B31]; [@B71]; [@B38]; [@B152]) and cholesterol-rich lipid rafts ([@B80]) than their normal counterparts. Nevertheless, in the last decade, a number of death receptors and downstream apoptotic signaling molecules have also been localized in cholesterol- and sphingolipid-rich lipid rafts in cancer cells ([@B48], [@B50], [@B51]; [@B44]; [@B108]; [@B131]; [@B104]). The localization of the death-inducing signaling complex (DISC), a major apoptotic complex containing Fas/CD95 death receptor, Fas-associated death domain-containing protein (FADD) and procaspase-8, in lipid rafts has been shown by electron microscopy in T cell leukemic cells, when they are engaged to undergo apoptosis ([@B45]). In addition, raft nanodomains have been shown, following a FCS strategy, to be present in both the outer and inner leaflets of the plasma membrane and to play a crucial role in triggering the survival phosphatidylinositol-3 kinase/Akt signaling pathway, by facilitating Akt recruitment and activation upon phosphatidylinositol-3,4,5-triphosphate accumulation in the plasma membrane ([@B75]). On these grounds, mammalian cell lipid rafts behave as platforms that can house different, and even opposite signaling processes, such as survival and apoptosis, and therefore these membrane domains play a critical role in the modulation of cell signaling that regulates cell fate.

Lipid rafts have also been identified in yeast as membrane domains enriched in ergosterol and sphingolipids ([@B159]). The budding yeast *Saccharomyces cerevisiae* is one of the best characterized eukaryotic organisms. In spite of its simplicity as a free-living unicellular fungus, yeast cells are similar to higher eukaryotes regarding the cell structure and several physiological processes. Due to its genetic tractability and increasing wealth of accessible data, yeast has become a model system of choice for the study of different physiological processes occurring in mammalian cells. In this regard, yeast could be an interesting biological system to analyze the role of lipid rafts in both survival and cell death responses, despite yeast lack death receptors and most of the typical apoptotic signaling molecules present in mammalian cells.

RAFTS IN YEASTS
===============

Regarding the lipid constituents of lipid rafts, and although the lipid levels vary between different cell types, the plasma membrane of the mammalian cell usually contains, on a molar basis, about 30--40% cholesterol and 10--20% sphingomyelin of plasma membrane lipids, while glycosphingolipids are usually present at low levels ([@B74]; [@B156]). However, yeasts do not have sphingomyelin, but instead have inositol phosphosphingolipids, which may function as orthologs of mammalian sphingomyelin ([@B98]). In addition, unlike mammalian cells that have cholesterol, yeast contain ergosterol, serving the same function as cholesterol in animal cells. Ergosterol is even a better raft former than cholesterol ([@B165]). Studies on the generation of model membranes from yeast total lipid extracts led to the conclusion that formation of membrane domains depended on specific interactions between yeast sphingolipids and ergosterol ([@B69]). This selective interaction between yeast sphingolipids and ergosterol results in phase separation into membrane domains with liquid ordered- and liquid disordered-like properties, that is in raft formation ([@B69]). Thus, whereas lipid rafts in mammalian cells contain cholesterol and sphingomyelin or glycosphingolipids ([@B144]), raft domains in *S. cerevisiae* contain ergosterol and complex sphingolipids ([@B72]; [@B6]), including inositol-phosphoceramide (IPC), mannose-inositol-phosphoceramide (MIPC), and mannose-(inositol phosphate)~2~-ceramide (M(IP)2C) ([@B32]).

Lipid rafts are enriched in sterols, composed of a four-ring structure with an aliphatic tail that can pack tightly with the lipid acyl chains of sphingolipids to create a compacted region of condensed bilayer termed the liquid-ordered state ([@B114]; [@B100]). Because of its rather unique lipid composition, lipid rafts are more resistant to extraction with cold non-ionic detergents, and therefore they were originally defined as DRMs, due to their relative insolubility in cold non-ionic detergents ([@B84]; [@B99]; [@B143]). In the yeast, rafts have also been defined biochemically as DRMs and proven to be critical for protein sorting through the endoplasmic reticulum and Golgi apparatus ([@B6], [@B5]; [@B7]). The terms lipid raft, liquid-ordered domain, and DRM are widely used indistinctly and are suggested to refer to the same chemico-biological entity. However, in a very strict way, they might have different implications and caution should be taken ([@B81]).

The yeast sphingolipid is peculiar in that it contains a saturated very long-chain fatty acid with 26 carbon atoms ([@B136], [@B135]), which is synthesized and coupled to raft-located proteins, like the proton pumping ATPase Pma1p, already in the endoplasmic reticulum. Then, the resulting protein--lipid complex is transported and sorted as an entity to the plasma membrane. This rather long C26 fatty acid is required for proper assembly of the protein--lipid complex and transport to the membrane, as a shortening to C22 fatty acid by mutations impairs raft association of Pma1p, and induces Pma1p degradation by rerouting the ATPase enzyme from the plasma membrane to the vacuole ([@B43]; [@B153]).

Another important difference between mammalian cells and yeast cells lies in that lipid raft formation occurs primarily in the Golgi apparatus in mammals ([@B16]), whereas it takes place in the endoplasmic reticulum in yeast, where is suggested that proteins associate with yeast rafts ([@B6]). In both yeast and mammalian cells, sphingolipids and sterols are mainly present in the plasma membrane ([@B74]; [@B121]; [@B175]), but these molecules are synthesized in compartments of the early secretory pathway ([@B29]; [@B39]), and therefore raft-located proteins could be recruited into these domains in other subcellular structures distinct from the plasma membrane. Thus, in yeast newly synthesized Gas1p, a GPI-anchored protein, and Pma1p have been found to be recruited to lipid rafts in the endoplasmic reticulum ([@B6]; [@B78]).

Because a major constituent of lipid rafts is sterol, the naturally fluorescent sterol-binding antibiotic filipin has been widely used to detect regions with high sterol content in the plasma membrane of fungi. The use of this compound has led to the identification of large sterol-rich domains (SRDs) in the plasma membranes of fungi ([@B160]; [@B1]), ranging from about 3 to 15 μm^2^. Due to the dynamic nature of lipid rafts and to their ability to aggregate, clusters of rafts in mammalian cells can be formed under different stimuli to lead to raft platforms as big as the ones reported for some fungi ([@B2]). In this regard, it might be envisaged that SRDs in yeasts correspond to clusters of sterol-rich rafts or raft platforms, which are required for the accomplishment of specific functions. This clustering of rafts may be critical for the proper onset of certain cell functions, which might require the concentration of a great amount of proteins in specific sites of the cell, thus leading to cell movement, cytokinesis, etc. On these grounds, lipid rafts act as dynamic and mobile platforms that transport the required proteins at the proper place to act.

Sterol-rich membrane domains have been identified in several fungal species, including the budding yeast *S. cerevisiae* ([@B72]; [@B5]), the fission yeast *Schizosaccharomyces pombe* ([@B160]), as well as the pathogen yeasts *Candida albicans* ([@B97]; [@B1]) and *Cryptococcus neoformans* ([@B141]; [@B1]), having being involved in a number of important processes like mating ([@B115]; [@B129]), cytokinesis ([@B130]; [@B160]), and hyphal formation ([@B97]).

Sterol-rich domains are polarized in the rod-shaped *S. pombe* throughout the vegetative life cycle in a cell cycle-dependent way, namely they are located to the growing cell ends during interphase, and to the medial zone where cells undergo cytokinesis, as well as at the tips of mating projections ([@B130]; [@B160]; [@B159]; [@B1]). Thus, in fission yeast, rafts localize to regions of polarized growth and to the division site. Unlike to what happens in *S. pombe*, sterols are distributed uniformly throughout the plasma membrane in the vegetative life cycle of the budding yeast *S. cerevisiae*. However, filipin-stained rafts are also detected at the tips of cells induced with mating pheromone ([@B7]; [@B129]; [@B1]). In the human pathogens *C. neoformans* and *C. albicans*, sterols are concentrated at the leading edges of mating projections, at the actively growing sites at bud tips, at sites of septation, and at the tip of hyphal growth ([@B97]; [@B1]).

RAFTS IN YEAST PATHOGENS
========================

Proteomic analysis in DRMs from *C. albicans* led to the identification of 29 proteins, including the well-known lipid raft marker in *S. cerevisiae* Pma1p ([@B66]). Surprisingly, only three proteins (\~10%) were typically located in the plasma membrane, whereas most of raft-located proteins were usually present in internal membranes, including proteins located in mitochondrial (31%), Golgi (7%), and endoplasmic reticulum (7%) membranes. This could support the existence of raft domains in the membranes of mitochondria, endoplasmic reticulum, and Golgi, as reported by different researchers ([@B10]; [@B102]; [@B106]). The proteins located in *C. albicans* rafts were involved in a number of biological processes, including lipid metabolism, cell wall biogenesis, protein metabolism, electron transport, and ATP synthesis ([@B66]). In addition heat shock proteins were also present ([@B66]), similarly to what has been observed in mammalian cells ([@B116]). Likewise, ATP synthase was also located at the raft membranes in *C. albicans* ([@B66]), and a similar raft location for this enzyme has been found in proteomic studies conducted in mammalian cells ([@B4]), leading to the suggestion that this protein might be located in plasma membrane rafts as well as in mitochondria ([@B4]). Furthermore, it is worth mentioning the presence in *C. albicans* lipid rafts of a series of proteins involved in lipid metabolism and multidrug efflux, such as: Erg11p and Scs7p, involved in the lipid metabolism of major raft components (ergosterol and ceramide; [@B66]); Rta2p, a translocase that moves sphingolipid long chain bases from the inside to the outside membrane ([@B163]); and the ATP-binding cassette (ABC) multidrug transporter CaCdr1p ([@B119]). The presence of cytosolic proteins in the *C. albicans* rafts suggest that protein--protein interactions could play a major role in bringing soluble proteins to the raft domains.

*Candida albicans*-associated bloodstream infections are linked to the ability of this yeast to form biofilms ([@B113]). These latter are aggregates of microbial cells, adhering to each other, which are embedded within a self-produced matrix of extracellular polymeric substances, usually made up of extracellular DNA, proteins, and polysaccharides, and represent a common mode of microbial growth. Microbes growing as biofilm are highly resistant to commonly used antimicrobial drugs. *Candida* biofilms associated with indwelling devices provide a protected niche for the fungal cells, where they can evade the host immune system, and are especially problematic due to their inherent resistance to commonly used antifungal agents ([@B20]). The microbial cells growing in a biofilm are physiologically distinct from planktonic cells of the same organism, which are single-cells floating in a liquid medium. Biofilm formation by *Candida* species is believed to contribute to invasiveness of these fungal species, and there is a correlation between *C. albicans* biofilms and fungal pathogenesis. By using lipidomics, a significant difference was observed in the lipid profiles of *C. albicans* biofilms and planktonic cells. Biofilms contained higher levels of phospholipid and sphingolipids than planktonic cells. In the early phase, levels of lipid in most classes were significantly higher in biofilms compared to planktonic cells. The unsaturation index of phospholipids decreased with time, with this effect being particularly strong for biofilms. Inhibition of the biosynthetic pathway for sphingolipid (M(IP)2C) by myriocin or aureobasidin A, and disruption of the gene encoding inositolphosphotransferase 1 (*IPT1*), abrogated the ability of *C. albicans* to form biofilms, suggesting that lipid rafts might be involved in biofilm formation ([@B76]). The differences in lipid profiles between biofilms and planktonic *Candida* cells may have important implications for the biology and antifungal resistance of biofilms ([@B76]).

In addition, lipid rafts have been found to be important platforms for the concentration of certain virulence factors at the cell surface of pathogenic fungi, to allow efficient access to enzyme substrate and/or to provide rapid release to the external environment. Thus, rafts from the fungal pathogen *C. neoformans* contain the virulence determinant phospholipase B1 (Plb1p), a GPI-anchored protein, and the antioxidant virulence factor Cu/Zn superoxide dismutase (Sod1p; [@B141]). The enzyme Plb1p contains phospholipase B (PLB), lysophospholipase (LPL), and LPL transacylase (LPTA) activities ([@B21],[@B22]), and therefore it might affect raft lipid composition.

LIPID RAFTS AND ION HOMEOSTASIS IN YEAST
========================================

The maintenance of ion homeostasis in response to changes in the environment is vital to all living cells. In yeast cells, the active transport of inorganic ions and nutrients relies on the existence of an electrochemical gradient of protons across the plasma membrane. In *S. cerevisiae*, this electrochemical gradient is mainly generated by the essential H^+^-ATPase gene, *PMA1*, which encodes one of the most abundant proteins in the yeast plasma membrane ([@B138]). This Pma1p-mediated electrochemical gradient is balanced by the activity of a number of symporters and antiporters, but the high-affinity potassium uptake through the plasma membrane transporters Trk1p and Trk2p, the former being the most biologically relevant potassium transporter, is the major consumer of the gradient ([@B41]; [@B70]; [@B90]). Potassium transport into yeast cells results in plasma membrane depolarization, leading to Pma1p stimulation and a concomitant cytosolic alkalinization ([@B133]). Thus, the regulation of both Pma1p and Trk1p is critical for the modulation of the electrical membrane potential and intracellular pH. Thus, Pma1p and the high-affinity potassium transporters Trk1p and Trk2p are the major determinants of yeast membrane potential and internal pH, and thus should be co-ordinately regulated. The plasma membrane proton ATPase Pma1p is a resident raft protein ([@B5]). The major K^+^ transporters, Trk1p and Trk2p, have also been reported to be present in lipid rafts ([@B171]; [@B166]). Intracellular pH plays a critical role in modulating the activity of many cellular systems, including those regulating cell death, both in yeasts ([@B86], [@B85]; [@B147]) and mammalian cells ([@B123]; [@B55]; [@B101]).

In *S. cerevisiae*, intracellular pH and K^+^ concentrations affect many cellular activities, including cell growth and death, and thereby they must be tightly controlled through the regulation of the H^+^-pumping ATPase Pma1p and the major K^+^ transporters Trk1p and Trk2p ([@B167] ,[@B166]). Pma1p is an electrogenic pump with an optimal pH of 6.5 and therefore is well suited to set the intracellular pH at a neutral value ([@B127]), and together with Trk1p, both systems are the major regulators of cell volume, turgor, membrane potential, and pH in yeast. Potassium accumulation through Trk1p can be harmful to the cell, leading to an increase in turgor pressure and the risk of cell lysis. Trk1p is activated by Hal4p and Hal5p kinases and inhibited by the Ppz1p and Ppz2p phosphatases. Hal3p is a negative regulatory subunit of the Ppz1p Ser/Thr phosphatase ([@B30]), and it has been shown that the inhibition of Ppz1p by Hal3p is pH dependent ([@B166]). Interestingly, Ppz1p--Hal3p interaction would act as an intracellular pH sensor, and a model has been proposed for the modulation of H^+^ and K^+^ homeostasis through the regulation of Trk1p activity by intracellular pH ([@B166]). At a relatively alkaline pH the interaction between Hal3p and Ppz1p would be destabilized, and hence the Ppz1p phosphatase would act on Trk1p to decrease the potassium uptake into the cell. Thus, following accumulation of K^+^, cells use then a concomitant increase in intracellular pH through the extrusion of protons by Pma1p to downregulate potassium transport.

Ppz1p has been mostly located at the plasma membrane, although some of this protein was also present in internal non-vacuolar membranes, likely the endoplasmic reticulum and/or the nuclear membrane ([@B166]). However, unlike Trk1p, Ppz1p was not found in DRMs ([@B166]). Nevertheless, because the raft-located Trk1p has been shown to interact with Ppz1p ([@B166]), it cannot be ruled out that lipid rafts might transiently be a place where these proteins could interact each other, as shown for other non-raft proteins in mammalian cells that are translocated and recruited in lipid rafts to regulate cell death signaling ([@B44]; [@B51]; [@B116]; [@B131]).

The above data on yeast are of major importance for mammalian cells, as regulation of potassium transport and intracellular pH homeostasis is implicated in many diseases ([@B140]), including cancer, and it is plausible to envisage that similar transduction pathways connecting pH and potassium homeostasis might play a critical role in human disease and constitute interesting therapeutic opportunities.

In addition, the plasma membrane Na^+^/H^+^ antiporter Nha1p from the budding yeast *S. cerevisiae*, which plays an important role in intracellular Na^+^ as well as pH homeostasis, by mediating the exchange of Na^+^ for H^+^ across the plasma membrane, has also been shown to associate with lipid rafts ([@B103]). In *lcb1-100* mutant cells, which are temperature-sensitive for sphingolipid synthesis, newly synthesized Nha1p failed to localize to the plasma membrane at the non-permissive temperature, but the addition of phytosphingosine or the inhibition of endocytosis in *lcb1-100* cells restored the targeting of Nha1p to the plasma membrane ([@B103]).

Thus, Pma1p, Trk1p, and Nha1p, regulating membrane potential and intracellular pH, are located in lipid rafts in *S. cerevisiae* (**Figure [1](#F1){ref-type="fig"}**), and they are critical in the modulation of ion homeostasis, by keeping the major monovalent cations (H^+^, K^+^, and Na^+^), mainly through proteins that extrude H^+^ and Na^+^ and import K^+^ ions (**Figure [1](#F1){ref-type="fig"}**), at the appropriate narrow range of ion concentrations for the proper function of distinct biological processes.

![**Ion homeostasis in yeast.** This scheme portrays the major proteins, Pma1p, Trk1p, Trk2p, and Nha1p, involved in maintaining ion homeostasis in *S. cerevisiae*.](fonc-02-00140-g001){#F1}

NUTRIENT TRANSPORTERS IN YEAST LIPID RAFTS
==========================================

**Table [1](#T1){ref-type="table"}** shows a number of proteins that have been located in lipid rafts in *S. cerevisiae*, including proteins involved in ion homeostasis, nutrient transport, mating, stress response, and actin cytoskeleton organization.

###### 

Proteins associated with lipid rafts in *S. cerevisiae*.

  Gene            Description                                                              Biological process                                                           Major localization                            Technical approach   Reference
  --------------- ------------------------------------------------------------------------ ---------------------------------------------------------------------------- --------------------------------------------- -------------------- -----------
  *PMA1*          Plasma membrane ATPase                                                   Proton transport, pH regulation                                              Plasma membrane                               DRMGC                [@B5]
  *TRK1*          Potassium transporter                                                    Cellular potassium ion homeostasis                                           Plasma membrane                               DRMGC                [@B166]
  *TRK2*          Potassium transporter                                                    Cellular potassium ion homeostasis                                           Plasma membrane                               RTE                  [@B171]
  *NHA1*          Na^+^/H^+^ antiporter                                                    Ion homeostasis                                                              Plasma membrane                               DRMGC                [@B103]
  *TAT2*          Tryptophan transporter                                                   Tryptophan transport                                                         Plasma membrane                               DRMGC                [@B155]
  *CAN1*          Arginine permease                                                        Arginine transport                                                           Plasma membrane                               DRMGC                [@B91]
  *GAP1*          General amino acid permease                                              Amino acid transport                                                         Plasma membrane                               DRMGC                [@B77]
  *HXT1*          Low-affinity glucose transporter                                         Glucose transport, hexose transport                                          Plasma membrane                               DRMGC                [@B77]
  *FUR4*          Uracil permease                                                          Uracil transport                                                             Plasma membrane                               DRMGC                [@B60]
  *FUS1*          Cell FUSion                                                              Mating                                                                       Mating projection tip                         DRMGC                [@B7]
  *FUS2*          Cell FUSion                                                              Mating                                                                       Mating projection tip                         DRMGC                [@B7]
  *FIG1*          Factor-induced gene                                                      Mating                                                                       Mating projection tip                         DRMGC                [@B7]
  *SHO1*          Transmembrane osmosensor                                                 Osmosensor activity, mating                                                  Plasma membrane, mating projection tip        DRMGC                [@B7]
  *STE6*          Plasma membrane ATP-binding cassette (ABC) transporter                   Peptide pheromone export, mating                                             Plasma membrane, mating projection tip        DRMGC                [@B7]
  *PRM1*          Pheromone-regulated membrane protein                                     Response to pheromone, mating                                                Mating projection tip                         DRMGC                [@B7]
  *SLG1/WSC1*     Sensor-transducer of the stress-activated PKC1-MPK1                      Response to heat and osmotic stress, actin depolarization                    Plasma membrane, mating projecting tip        RTE                  [@B83]
  *RVS161*        Amphiphysin-like protein                                                 Actin cytoskeleton organization, response to osmotic stress and starvation   Actin cortical patch, mating projecting tip   RTE                  [@B8]
  *RVS167*        Amphiphysin-like protein                                                 Lipid tube assembly                                                          Actin cortical patch, mating projecting tip   RTE                  [@B54]
  *GAS1*          Glycophospholipid-anchored surface protein/β-1,3-glucanosyltransferase   Fungal-type cell wall organization                                           Plasma membrane, cellular bud scar            DRMGC                [@B6]
  *HSP30*         Heat shock protein                                                       Stress response, negative regulation of Pma1p                                Plasma membrane                               DRMGC                [@B6]
  *MRH1*          Membrane protein related to Hsp30p                                       Unknown                                                                      Plasma membrane, mitochondrion                DRMGC                [@B6]
  *NCE2/NCE102*   Non-classical export                                                     Plasma membrane organization                                                 Plasma membrane                               DRMGC                [@B6]

DRMGC, non-ionic detergent-resistant membrane (DRM) fractions at 4°C followed by flotation in density gradient centrifugation; RTE, resistance to Triton X-100 extraction.

Several nutrient transporters have been located in lipid rafts in *S. cerevisiae* (**Table [1](#T1){ref-type="table"}**). The arginine/H^+^ symporter Can1p (arginine permease) has been found to be present in lipid rafts in *S. cerevisiae* ([@B91]). Double labeling experiments with Can1p-GFP and Pma1p-RFP-containing yeast cells showed that these proteins were located in two different non-overlapping membrane domains ([@B91]), suggesting the presence of distinct rafts in the same yeast cell. The general amino acid permease Gap1p present at the plasma membrane is also associated with DRMs, and in the absence of sphingolipid synthesis Gap1p fails to accumulate at the plasma membrane and is missorted to the vacuole ([@B77]). Likewise, the hexose transporter Hxt1p (low-affinity glucose permease) present at the cell surface was also associated with DRMs ([@B77]). The plasma membrane protein uracil/H^+^ symporter Fur4p (uracil permease) has also been reported to be associated with lipid rafts in *S. cerevisiae* ([@B60]). The amount of this protein in plasma membrane is highly regulated. Under stress conditions, including heat stress and high concentrations of uracil in the culture medium, Fur4p is degraded by a process that includes phosphorylation, ubiquitination, endocytosis, and transport to the vacuole where the protein is eventually hydrolyzed ([@B52]; [@B94]). Because rafts act as platforms for the integration and modulation of signaling pathways and processes, it could be envisaged that the raft location of Fur4p might be critical for its regulation.

The plasma membrane localization of the tryptophan permease Tat2p is regulated by the external tryptophan concentration and is dependent on lipid rafts. In wild-type cells, Tat2p is transported from the Golgi apparatus to the vacuole at high tryptophan level, and to the plasma membrane at low tryptophan level. However, Tat2p is missorted to the vacuole at low tryptophan concentration in the *erg6*Δ deleted mutant (*ERG6* gene encodes *S*-adenosylmethionine Δ24 methyltransferase, acting in the last steps of ergosterol biosynthesis by converting zymosterol to fecosterol; [@B155]), and following yeast treatment with the ergosterol biosynthesis inhibitor zaragozic acid, that inhibits squalene synthetase, which catalyzes the first committed step in the formation of cholesterol/ergosterol ([@B28]). Likewise, additional proteins, such as Fus1p, a plasma membrane protein required for yeast mating, is excluded from rafts and missorted to the vacuole in the *erg6*Δ mutant ([@B7]). These evidences support the view that several plasma membrane proteins can be missorted in *erg6*Δ mutants due to impaired raft association, and this might underlie the mating deficiency ([@B40]) and drug hypersensitivity ([@B68]; [@B59]; [@B95]) of *erg6*Δ mutants.

Furthermore, as shown in **Table [1](#T1){ref-type="table"}**, mating projection-localized proteins Fus2p, Fig1p, Sho1p, Ste6p, and Prm1p have been found to be associated with DRMs ([@B7]), supporting a critical role for lipid rafts in the mating process.

RAFTS AND CELL DEATH IN YEAST
=============================

Dysregulation of ion homeostasis mediates cell death, and this represents the mechanistic basis by which a growing number of amphipathic but structurally unrelated compounds elicit antifungal activity ([@B172]). Pma1p is displaced from lipid rafts and delivered and degraded to the vacuole upon *S. cerevisiae* incubation with edelfosine ([@B170]), an amphipathic antitumor ether phospholipid that affects and reorganizes lipid rafts ([@B44], [@B45]; [@B2]). Because Pma1p is mainly involved in maintaining ion homeostasis and membrane potential in yeast, its displacement from lipid rafts, following treatment of *S. cerevisiae* with the ether phospholipid edelfosine, has been shown to lead to yeast cell death ([@B170]). Edelfosine has been reported to have affinity for cholesterol, and for cholesterol-rich membranes such as rafts ([@B2]; [@B17]), because of the complementarity of the molecular geometrics of sterols and edelfosine ([@B17]). Edelfosine induces apoptotic cell death in a wide number of human cancer cells ([@B107], [@B111], [@B104],[@B105]; [@B49], [@B51]; [@B47]) through raft reorganization and redistribution of the raft protein content ([@B48], [@B51]; [@B44], [@B45]). In human hematopoietic cancer cells, edelfosine treatment leads to the recruitment of apoptotic molecules into raft platforms, thus leading to the emerging concept of an apoptotic "liquid-ordered" plasma membrane platform named as "cluster of apoptotic signaling molecule-enriched rafts" (CASMERs; [@B50]; [@B46]; [@B109],[@B110]). These CASMERs may reduce the apoptotic signal threshold by facilitating and stabilizing protein--protein interactions and cross-talk between signaling pathways, and thereby act as a membrane signaling platforms to launch and catalyze the transmission of apoptotic signals ([@B109],[@B110]). The protein composition of these CASMERs includes death receptors and downstream signaling molecules ([@B50]; [@B46]; [@B109],[@B110]). On these grounds, lipid rafts play a major role in the generation of apoptotic signals in mammalian cells. In contrast to mammalian cells, yeasts lack death receptors and most of the typical apoptotic molecules, so the involvement of rafts in the cell death process might be less obvious in yeast. However, lipid rafts seem to be critical structures and scaffolds for the proper function of proteins whose activities are required for the normal function of a yeast cell, including yeast survival and growth (**Figure [2](#F2){ref-type="fig"}**), such as proteins involved in ion homeostasis and nutrient transport (**Table [1](#T1){ref-type="table"}**). In this regard, it might be envisaged that redistribution and displacement of raft-located proteins to non-raft domains might lead to a failure in yeast functioning and eventually to cell death.

![**Putative involvement of lipid rafts in different yeast functions**.](fonc-02-00140-g002){#F2}

In mammalian cells, lipid rafts usually house proteins involved in survival signaling and growth, and thereby their presence is expected to play a role in the proliferation and survival of cancer cells. However, as indicated above, recent evidence in the last few years has also shown the presence of rafts enriched in death receptors and apoptotic molecules, leading to the emerging concept of the proapoptotic CASMER. Thus, at least two major different raft domains leading to survival and cell death can apparently be formed in mammalian cells. However, because yeast cells lack death receptors and the classical mammalian-like caspases, yeast rafts are supposed to be involved only in rather positive outcomes that keep the yeast cell alive. According to this notion, it might be envisaged that lipid raft disruption could facilitate and prompt yeast cell death.

The cationic amphipathic and antiarrhythmic drug amiodarone interacts with lipid membranes to exert their biological effect. In *S. cerevisiae*, toxic levels of amiodarone trigger a transient membrane hyperpolarization, likely through its ability to intercalate into the lipid bilayer ([@B63]) altering lipid fluidity ([@B134]), which is followed by depolarization, coincident with influx of Ca^2+^ and H^+^ that can overwhelm cellular homeostasis and lead to cell death ([@B95]). Amiodarone has been shown to have potent fungicidal activity against not only *S. cerevisiae*, but also for species of *Cryptococcus*, *Candida*, *Fusarium*, and *Aspergillus* ([@B26]). Using a genome-wide screen in a *S. cerevisiae* single-gene deletion library, 36 yeast strains with amiodarone hypersensitivity were identified, including mutants in transporters (*PMR1*, *PDR5*, vacuolar H^+^-ATPase), ergosterol biosynthesis (*ERG3*, *ERG6*, *ERG24*), intracellular trafficking (*VPS45*, *RCY1*), and signaling (*YPK1*, *PTC1*; [@B59]). The fact that azole resistant mutants in the ergosterol biosynthesis pathway of *S. cerevisiae* (*erg3*Δ, *erg6*Δ, and *erg24*Δ) exhibited hypersensitivity to amiodarone, suggests that the drug may be particularly effective for treatment against azole-resistant fungal strains ([@B59]), which might be defective in raft-mediated processes. In addition, low doses of amiodarone and an azole (miconazole, fluconazole) are strongly synergistic and show potent fungicidal effects in combination ([@B59]). These data suggest that lipid raft disruption might favor amiodarone cytotoxic action against yeast.

The initial hyperpolarization seems to be critical for the amiodarone cytotoxic effect. Glucose increases membrane potential by increasing H^+^ pumping activity of the plasma membrane ATPase Pma1p ([@B137]). Downregulation of the H^+^ pump activity of the yeast plasma membrane upon glucose removal ([@B137]) was accompanied by an attenuation of amiodarone-induced Ca^2+^ burst, thus protecting against drug toxicity ([@B112]). Amiodarone-induced hyperpolarization was lower in the mutant strain *pma1-105* that has 65% reduction in activity ([@B124]). Furthermore, a decrease in membrane potential by glucose removal, addition of salts or in *tok1*Δ, *ena1-4*Δ, or *nha1*Δ mutants, involved in ion homeostasis, protected against amiodarone toxicity, suggesting that initial hyperpolarization was important in the mechanism of antifungal activity ([@B95]). Thus, there is a link between membrane hyperpolarization and amiodarone toxicity. Because ion homeostasis and membrane potential is mainly regulated by raft-located proteins, these data also involve these membrane domains in the cytotoxicity of certain fungal drugs.

Interestingly, a recent work by [@B154] has shown that deletion of *GUP1* in *S. cerevisiae* leads to hypersensitivity to acetic acid treatment, high levels of reactive oxygen species (ROS) and reduced lifespan, leading to yeast cell death, likely through necrosis rather than apoptosis. Gup1p is a membrane-bound *O*-acyltransferase involved in remodeling GPI anchors ([@B12]), playing an important role in the assembly/integrity of lipid rafts ([@B36]). Because *gup1*Δ mutant is affected in lipid raft integrity/assembly, lipid metabolism, and GPI-anchor remodeling, the above data ([@B154]) suggest a role of lipid rafts in yeast cell death process, and in the type of cell death process that ensues reorganization of plasma membrane domains.

Cytotoxicity of the antitumor ether phospholipid edelfosine against *S. cerevisiae* has been shown to be enhanced in yeast mutants defective for *LCB1*, an essential serine palmitoyltransferase that catalyzes the first step in sphingolipid synthesis, and *ERG3*, a sterol C-5 desaturase involved in the final steps of ergosterol synthesis ([@B170]). On the other hand, *S. cerevisiae* mutants affected in sphingolipid and ergosterol biosynthesis, namely *ipt1*Δ, *sur1*Δ, *skn1*Δ, and *erg3*Δ deletion mutants, are resistant to the azole antimycotics miconazole, mainly due to the role of lipid rafts in mediating intracellular accumulation of miconazole in yeast cells ([@B37]). Taken together these data suggest a major role of lipid rafts in the cytotoxicity of drugs in yeast.

In this regard, a number of data support that absence of ergosterol, which is one of the major constituents of membrane rafts, has a direct effect on drug susceptibility and morphogenesis of *C. albicans*. Low doses of amiodarone have been reported to be synergistic with fluconazole in fluconazole-resistant *C. albicans* ([@B53]). Ergosterol deficiency in *erg1*Δ mutants led to defects in growth and increased susceptibilities to drugs, including fluconazole, ketoconazole, cycloheximide, nystatin, amphotericin B, and terbinafine in *C. albicans* ([@B118],[@B120]). Reduced drug efflux activity of the *erg1*Δ mutant was associated with poor surface localization of Cdr1p, suggesting that enhanced passive diffusion and reduced efflux mediated by the ABC transporter Cdr1p increases drug susceptibility. Additionally, conditional *erg1*Δ mutant strains were unable to form hyphae in various media in *C. albicans* ([@B118],[@B120]). Likewise, the loss of (M(IP)2C) in the *C. albicans* *ipt1*Δ mutant, a sphingolipid biosynthetic gene, resulted in increased sensitivity to drugs like 4-nitroquinoline oxide, terbinafine, *o*-phenanthroline, fluconazole, itraconazole, and ketoconazole. The increase in drug susceptibilities of *ipt1*Δ mutant cells was linked to an altered sphingolipid composition, which appeared to be due to the impaired functionality of Cdr1p, a major drug efflux pump of *C. albicans* that belongs to the ABC superfamily ([@B128]). Taken together, the above data indicate that an altered composition of sphingolipid or ergosterol, the major constituents of membrane rafts, affects drug susceptibility and morphogenesis in *C. albicans*.

ACTIN CYTOSKELETON, RAFTS, AND STRESS RESPONSE
==============================================

Wild-type *S. cerevisiae* cells depolarize actin following salt stress and repolarize after a period of adaptation ([@B25]; [@B8]). Two proteins are mainly involved in this process, namely Wsc1p for actin depolarization and the amphiphysin-like protein Rvs161p for actin repolarization ([@B8]). Thus, *rvs161*Δ mutant was able to depolarize actin in response to NaCl stress, but was unable to repolarize afterward, whereas *wsc1*Δ mutants was impaired in depolarizing actin ([@B8]). *RVS161/END6* gene, the budding yeast homolog of amphiphysin ([@B146]; [@B168]), is associated, in part, with lipid rafts ([@B8]), and co-localizes with actin patches ([@B9]), thus suggesting a link between rafts and actin cytoskeleton in *S. cerevisiae*. Rvs161p is suggested to locate in rafts through a putative association with a raft-bound protein, as Rvs161p has no GPI signal anchor or transmembrane domain, and therefore it cannot be directly integrated in rafts. The *SLG1/WSC1* gene product has also been reported to be partially present in DRMs ([@B83]). Clustering of Slg1p/Wsc1p is enhanced under stress conditions, either heat or hypo-osmotic shock, as assessed by single-molecule atomic force microscopy, suggesting its relevance in stress response ([@B62]). Thus, lipid rafts could function as platforms for actin depolarization and actin repolarization in response to stress in *S. cerevisiae*.

In yeast, nutrient starvation leads to entry into stationary phase. *RVS161* (RVS for [R]{.ul}educed [V]{.ul}iability upon [S]{.ul}tarvation) was identified as a critical gene to respond properly to carbon, nitrogen, and sulfur starvation conditions in *S. cerevisiae*, and it has been implicated in the control of cellular viability. Thus, *rvs161*Δ mutant cells die during the stationary phase and show sensitivity to high salt concentrations ([@B27]). *Rvs161*Δ displays a phenotype similar to that shown for the actin mutants: actin cytoskeleton disorganization, random budding of the diploids, loss of polarity, and sensitivity to salt. In addition, *rvs161*Δ, together with mutations in the actin gene, *ACT1*, leads to synthetic lethality ([@B13]), thus suggesting that actin and Rvs161p are linked in a common functional pathway that is critical for yeast viability under stress conditions. These data might suggest a role of lipid rafts as platforms for the interaction of proteins that are required for yeast survival.

Rvs167p, another amphiphysin-like protein that interacts with Rvs161p to regulate actin cytoskeleton, endocytosis, and viability following starvation and osmotic stress, has been reported to localize to Rvs161p-containing lipid rafts ([@B54]). Several protein networks involved in diverse cellular functions, including endocytosis/vesicle traffic, converge on Rvs161p-Rvs167p complex ([@B11]), and thereby Rvs167p-Rvs161p complex might act as a docking platform for proteins involved in the regulation of different biological processes requiring actin cytoskeleton ([@B54]). In addition, the *rvs* mutants accumulate late secretory vesicles at sites of membrane and cell wall construction, and are synthetic-lethal with the *slt2/mpk1*Δ mutation, which affects the MAP kinase cascade controlled by Pkc1p and is required for cell integrity ([@B14]). These data support the idea that the RVS proteins, and thereby lipid rafts, are involved in the late targeting of vesicles whose cargoes are required for cell wall construction.

Actin-linking proteins ezrin, moesin, RhoA, and RhoGDI were shown to be recruited into clusters of Fas/CD95-enriched rafts in human leukemic cells upon treatment with the anticancer drug aplidin ([@B50]). Disruption of lipid rafts and interference with actin cytoskeleton prevented Fas/CD95 clustering and apoptosis, suggesting a major role of actin cytoskeleton in the formation of Fas/CD95 clusters and in the aggregation of proteins in lipid raft clusters in human cancer cells, thus regulating raft-associated signaling events ([@B50]). There is increasing of evidence of structuring of rafts by the cortical actin cytoskeleton, including evidence that the actin cytoskeleton associates with rafts, and that many of the structural and functional properties of rafts require an intact actin cytoskeleton ([@B24]; [@B3]).

In yeast, stabilization of actin by addition of jasplakinolide, by point mutations in the *ACT1* gene, or by deletion of certain genes that regulate F-actin, leads to cell death. Yeast mutant lacking the gene *END3* shows stabilized actin and elevated levels of ROS, this phenotype being dependent on downstream elements of the Ras/cAMP pathway ([@B56]). Following yeast treatment with methyl-β-cyclodextrin, which depletes sterols from plasma membrane and disrupts lipid rafts, and manumycin A, that blocks prenylation, Ras2 membrane association and the level of ROS were reduced, and cell death progression was inhibited ([@B34]). These data suggest that lipid rafts in yeast could be somehow related to providing platforms for the generation of stable complexes that could launch pro-cell death signals. This could open the possibility that lipid rafts in yeast could provide appropriate membrane domains for pro-cell death signaling molecules, as it has been recently described in mammalian cells, and not only for survival and growth signaling. However, this pro-cell death view of rafts in yeast remains to be elucidated, and further studies as well as the molecular characterization of the putative processes involved will be required.

LIPID RAFTS AND EISOSOMES
=========================

Studies on the budding yeast *S. cerevisiae* have revealed that fungal plasma membranes are organized into different subdomains. Pma1p (plasma membrane H^+^-ATPase) and Can1p (H^+^-arginine symporter) have been located in lipid raft membrane domains, but, as stated above, these proteins occupy two different non-overlapping membrane microdomains ([@B91]). Thus, at least two different types of rafts can be distinguished in the yeast plasma membrane. Similarly to what was observed with Can1p, a family of integral membrane proteins, including Sur7p, Ynl194p, and Ydl222p, were visualized in cortical patches in *S. cerevisiae* ([@B169]). Current evidence suggests the existence of at least two subcellular compartments in the yeast plasma membrane, namely a raft-based membrane compartment represented by a network-like structure housing Pma1p, and another raft-based membrane compartment that houses a number of proton symporters (Can1p, Fur4p, Tat2p). These two raft domains, also named as the [m]{.ul}embrane [c]{.ul}ompartment occupied by [P]{.ul}ma1p (MCP) and [m]{.ul}embrane [c]{.ul}ompartment occupied by [C]{.ul}an1p (MCC; [@B92]; [@B58]), apparently require different lipids to keep their respective protein compositions (**Figure [3](#F3){ref-type="fig"}**). The proper sorting of Pma1p has been reported to be more dependent on sphingolipids, ceramide, and the C26 acyl chain that forms part of the ceramide ([@B78]; [@B42], [@B43]). However, sterols are required for the correct targeting of Tat2p ([@B155]). Thus, these data suggest the putative existence of raft domains more enriched in either sphingolipids or sterol-rich in the yeast membrane, each one containing a specific set of proteins, and this compartmentalization or lateral segregation seems to be dependent on the membrane potential ([@B58]). Plasma membrane depolarization caused reversible dispersion of the H^+^ symporters previously present in 300-nm patches ([@B58]). In addition, yeast plasma membrane seems to contain an additional subdomain named eisosomes (from the Greek "*eis*," meaning into or portal, and "*soma*," meaning body), which are immobile protein complexes, composed mainly of the cytoplasmic proteins Pil1p and Lsp1p at the plasma membrane that mark static sites of endocytosis ([@B162]). Pil1p and Lsp1p form punctuate clusters (eisosomes) on the cytoplasmic surface of the plasma membrane at MCC sites ([@B162]) and associate with the plasma membrane via their BAR domains (named for the Bin/Amphiphysin/Rvs proteins), that bind membranes and promote curvature ([@B174]). Eisosomes form at the sites of invaginations in the plasma membrane, being flanked by Can1p-rich MCC domains at the upper edges of the furrows, whereas Pil1p is located at the bottom of the furrow ([@B149]; [@B33]) and Sur7p, a protein involved in endocytosis, seems to be at the boundary between MCC and eisosomes (**Figure [3](#F3){ref-type="fig"}**). Microscopic and genetic analyses link these stable, ultrastructural assemblies, named eisosomes, to the endocytosis of both lipid and protein cargoes in cells, and are mainly composed of BAR domain proteins ([@B33]; [@B117]). Eisosomes have been suggested to function as organizing sites for endocytosis ([@B151]). Thus, degradation of the arginine permease Can1p induced by excess of its substrate required first Can1p release from MCC patches, and only then it was endocytosed ([@B57]), thus suggesting that the protein is to a large extent unavailable for endocytosis and subsequent degradation as long as it stays in the protective area of MCC ([@B93]). In this regard, rapidly moving endocytic marker proteins avoid raft domains, and consequently the raft domain-accumulated proton symporters show a reduced state of substrate-induced endocytosis and turnover ([@B93]). Genetic analysis of the MCC/eisosome components indicates that these domains broadly affect overall plasma membrane organization ([@B33]). The analysis of the major constituents of eisosomes, i.e., BAR proteins, is of major importance also in mammalian cells. BAR family proteins contribute to a range of cellular functions characterized by membrane and cytoskeletal remodeling, inducing membrane curvature and recruitment of effector proteins, with important consequences in several human disorders, including cancer cell invasiveness, as well as immune and neurologic disorders ([@B23]).

![**Schematic view of yeast MCP, MCC, and eisosome membrane subdomains**.](fonc-02-00140-g003){#F3}

PERSPECTIVES
============

Recognition of the presence of distinct domains at the cell membrane has been one of the most significant scientific achievements in the last decades. Lipid raft membrane domains are gaining momentum in current biology, and they seem to regulate a wide number of critical processes. Lipid rafts are variable in size and composition, and can change in a highly dynamic way both by recruiting and expelling components as well as by coalescing smaller raft units, forming large clusters. The presence of these membrane domains in all eukaryotic cells opens new ways to study the physiological role of rafts in distinct biological systems. The existence of lipid rafts in yeast has provided an excellent way to study the role of these membrane domains in different biological processes, due to the remarkable yeast genetic tractability. Thus, changes in ergosterol and sphingolipid composition, the major raft constituents in yeast, by disrupting key metabolic genes lead to improper surface localization of major proteins involved in keeping yeast viable against some external aggression, including proteins involved in ion homeostasis, drug efflux, and stress response. Yeast lipid rafts house proteins that are critical for the regulation of membrane potential, intracellular pH, and nutrient transport. In fact, the plasma membrane potential is mainly considered as the driving force for ion and nutrient translocation in yeast, and the correct location of the proteins involved in these processes in lipid rafts is crucial for the proper functioning of the yeast. Lipid rafts could also behave as scaffolds where proteins dock and concentrate to either launch signals to be transmitted to other parts of the cell or to build new structures required for cell integrity or cell division. Thus, yeast cells constitute an excellent biological system to analyze the role of lipid rafts in both survival and cell death responses, in spite of lacking most apoptotic molecules present in mammalian cells. Key proteins for yeast survival and proper yeast functioning are localized in lipid rafts, and their displacement from raft domains leads to cell death. In addition, drugs interacting with sterols affect lipid raft composition and membrane integrity and are detrimental to yeast. In addition, yeast plasma membrane contains at least three distinct subdomains that appear to have specialized functions, and they could interact each other. Understanding the dynamic structure of lipid rafts in yeast, as well as their mobility, composition, and biological role, will be of an inestimable value in getting a better insight into the role of these membrane domains in survival and cell death signaling. This insight will recognize the importance of membrane lipids in cellular function, highlighting lipid rafts as a new and promising therapeutic target ([@B108]), and could be useful for the search of novel antifungal agents and, following extrapolation to mammalian cells, to hopefully set up the underlying bases for the treatment of human diseases. Membrane compartmentalization in lipid rafts plays a key role in signaling process in mammalian cells, and this aspect might also be true in yeast as a plethora of processes seem to involve proteins located in these yeast membrane domains. Thus, a better knowledge of the yeast lipid raft composition and function might help us to gain insight in the regulation of critical processes regarding cell fate, which might be extrapolated to other organisms and could be valuable to conceive new approaches in the treatment of human diseases where cell death and survival are critical, such as cancer and neurodegenerative diseases.
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